Suppr超能文献

局部进展期不可切除胰腺癌行胰体尾切除术加腹腔干切除和肝动脉重建后的长期生存。

Long-term survival after distal pancreatectomy with celiac axis resection and hepatic artery reconstruction in the setting of locally advanced unresectable pancreatic cancer.

机构信息

Department of Surgery, Graduate School of Biochemical and Health Science, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Department of Gastroenterology Center, Hiroshima Memorial Hospital, 1-4-3 Honkawa-cho, Naka-ku, Hiroshima, 730-0802, Japan.

出版信息

Clin J Gastroenterol. 2022 Jun;15(3):635-641. doi: 10.1007/s12328-022-01621-9. Epub 2022 Mar 29.

Abstract

The long-term survival of patients with locally advanced, unresectable pancreatic cancer is extremely poor. We present our experience with a 67-year-old woman who had a 40-mm mass in the body of the pancreas. Tumor infiltration reached the gastroduodenal artery, celiac artery, common hepatic artery, and splenic artery. After 10 courses of FOLFIRINOX, 2 courses of gemcitabine plus nab-paclitaxel, and 6 courses of gemcitabine alone, we performed distal pancreatectomy with celiac axis resection and hepatic artery reconstruction. The bifurcation of the gastroduodenal artery and the proper hepatic artery had to be resected, after which we created 2 anastomoses: proper hepatic-to-middle colic artery, and second jejunal-to-right gastroepiploic artery. Histopathologic examination revealed an Evans grade IIb histologic response to prior treatment and verified the R0 resection status. The patient was discharged on postoperative day 30 after treatment of a grade B pancreatic fistula and is still alive, without recurrence, more than 5 years after initiation of treatment. This patient with locally advanced, unresectable pancreatic cancer achieved long-term survival through perioperative multidisciplinary treatment, including distal pancreatectomy with celiac axis resection and hepatic artery reconstruction. This aggressive procedure could be a treatment option for patients with locally advanced, unresectable pancreatic cancer.

摘要

局部晚期、不可切除的胰腺癌患者的长期生存情况极差。我们报告了一位 67 岁女性的病例,她的胰腺体部有一个 40mm 的肿块。肿瘤浸润达到胃十二指肠动脉、腹腔动脉、肝总动脉和脾动脉。在接受了 10 个疗程的 FOLFIRINOX、2 个疗程的吉西他滨联合 nab-紫杉醇和 6 个疗程的吉西他滨单药治疗后,我们进行了胰体尾部切除术、腹腔动脉切除和肝动脉重建。胃十二指肠动脉的分叉和肝固有动脉必须切除,然后我们进行了 2 个吻合:肝固有动脉至结肠中动脉吻合,第二空肠至胃网膜右动脉吻合。组织病理学检查显示,先前治疗的组织学反应为 Evans 分级 IIb,且证实了 R0 切除状态。患者在术后第 30 天出院,当时患有 B 级胰瘘,经过治疗后,目前已超过 5 年未复发,仍存活。这位局部晚期、不可切除的胰腺癌患者通过围手术期多学科治疗实现了长期生存,包括胰体尾部切除术、腹腔动脉切除和肝动脉重建。这种激进的手术方法可能是局部晚期、不可切除的胰腺癌患者的一种治疗选择。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验